Search NLS News

The manufacturing site, spanning 10,000 m2 is expected to initiate production of Mölnlycke wound care products at the end of 2026/early 2027.

The two companies have announced a strategic collaboration to advance next-generation biotherapeutics, they state.

Neogap Therapeutics has been awarded a SEK 1 million grant from Vinnova to initiate a collaborative project with Weill Cornell Medicine in New York, US.

Moberg Pharma has entered into an exclusive licensing agreement with Karo Healthcare regarding the commercialization of MOB-015 (Terclara) in Europe.

The multicentre, phase 3 human clinical trial will evaluate the efficacy and safety of the company's pharmaceutical, Combined Metabolic Activator, in patients with Alzheimer's disease.

The FDA has issued a complete response letter (CRL) for Alvotech’s Biologics License Application (BLA) for AVT05, in a prefilled syringe and autoinjector presentations, a biosimilar candidate to Simponi (golimumab).

Pfizer has filed a lawsuit against Metsera, its Board of Directors, and Novo Nordisk, in the Delaware Court of Chancery.

Sound Bioventures has joined the company's investor syndicate with a SEK 34 million investment.

Thermo Fisher Scientific has announced a definitive agreement to acquire Clario Holdings, a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for USD 8.875 billion in cash at close plus potential additional earnout and other payments in the future, largely dependent on performance.

Imagine your job involves meeting with entrepreneurs and researchers who are passionate about developing drugs that could transform or save lives, and realizing you could be part of that future. That is just another “day at the office” for Ester Sklarsky, who has been a principal for the Swedish venture capital firm Sound Bioventures for the past three and a half years.